“The differences in regulations between our and other countries conducting clinical trials”
On 23rd February, we invited the lecturer who were from a company and held a seminar under the title of “the differences in regulations between our and other countries conducting clinical trials” in order to acquire the knowledge necessary for global clinical research.
Prior to the seminar during the preparation period, since the stakeholders were limited on this topic, we were super anxious that not many people would be participated in on the day of seminar. However our negative expectations were betrayed in a good way and we welcomed nearly 50 attendees (audience) from not only the Department of Medial Innovation but also the Cardiovascular Medicine, Obstetrics and Gynecology, the division of Health Sciences and lots more, then the lecture was successfully done.
This seminar lasted about 90 minutes and the lecturer gave us information about the differences between Japan and foreign countries: especially the United State, Europe and Asia(Singapore and Korea) showing many good charts and examples.
In the last Q & A session, because the rich content questions raised from the attendees, the microphone runner needed to run around everywhere in the hall.
2017 fiscal year we are planning to hold a seminar about 7 times entitled "Academia Clinical Development Seminar". As of today, topics are shown below. We are going to post the seminar in detail on our homepage when prepared. We hope that these opportunity allow us to develop our knowledge with respect to conduct global clinical trials in the academic field.
[Table of Contents]
- 1. Clinical research and clinical trials in Japan
- 2. Differences in legal systems concerning clinical research and clinical trials in each country
- 3. ICH-GCP
- 4. Clinical research and clinical trials in the United States
- 5. Clinical research and clinical trials in Europe
- 6. Clinical research and clinical trials in Singapore
- 7. Clinical research and clinical trials in Korea